DY
AGN

Dowling & Yahnke’s Allergan Inc AGN Stock Holding History

Dowling & Yahnke’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,086
Closed -$428K – 299
2017
Q3 		$428K Sell
2,086
-11
-0.5% -$2.26K 0.04% 230
2017
Q2 		$510K Buy
2,097
+309
+17% +$75.2K 0.05% 214
2017
Q1 		$427K Buy
1,788
+258
+17% +$61.6K 0.05% 223
2016
Q4 		$321K Sell
1,530
-656
-30% -$138K 0.04% 233
2016
Q3 		$503K Buy
2,186
+41
+2% +$9.43K 0.06% 201
2016
Q2 		$496K Sell
2,145
-704
-25% -$163K 0.06% 201
2016
Q1 		$764K Buy
2,849
+271
+11% +$72.7K 0.09% 175
2015
Q4 		$806K Buy
2,578
+185
+8% +$57.8K 0.1% 169
2015
Q3 		$650K Buy
2,393
+706
+42% +$192K 0.09% 176
2015
Q2 		$512K Buy
+1,687
New +$512K 0.06% 196
2015
Q1 		– Sell
-1,805
Closed -$384K – 262
2014
Q4 		$384K Sell
1,805
-416
-19% -$82.7K 0.05% 209
2014
Q3 		$396K Buy
2,221
+125
+6% +$20.8K 0.05% 200
2014
Q2 		$355K Sell
2,096
-230
-10% -$35.8K 0.05% 221
2014
Q1 		$289K Buy
2,326
+170
+8% +$20.7K 0.04% 236
2013
Q4 		$239K Buy
+2,156
New +$206K 0.03% 227

Other funds holding AGN

FIM
Frontier Investment Management Dallas, Texas $1.62B AUM 1.86% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CA
Callahan Advisors Houston, Texas $1.2B AUM 22.34% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return
CAM
Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
ARMC
American Research & Management Company Marion, Massachusetts $362M AUM 8.06% 1-Year Est. Return

Dowling & Yahnke's AGN Position: Q4 2017 in Review

Dowling & Yahnke sold out of Allergan Inc (AGN) in Q4 2017, closing a stake of 2,086 shares — an estimated $428K sold.

Dowling & Yahnke first reported a position in AGN in Q4 2013 and held it in 15 quarters. The position peaked at $806K in Q4 2015. 9 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Dowling & Yahnke reported no remaining Allergan Inc position as of Q4 2017 after selling out during the quarter.
  • Dowling & Yahnke sold 2,086 Allergan Inc shares in Q4 2017, an estimated $428K.
  • Dowling & Yahnke first reported a position in Allergan Inc in Q4 2013 and held it in 15 quarters.
  • Dowling & Yahnke's Allergan Inc position peaked at $806K in Q4 2015.
  • 9 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2017.

Based on Dowling & Yahnke's 13F filing for Q4 2017, filed 2 Feb 2018.